Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Baxter
AstraZeneca
Daiichi Sankyo
Argus Health
Cantor Fitzgerald
Deloitte
Fish and Richardson
Julphar

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,918,068

« Back to Dashboard

Summary for Patent: 4,918,068
Title: Cephem compounds
Abstract:There are provided new cephem compounds (synisomers) represented by the following general formula (I): ##STR1## wherein R.sup.1 means a lower group, R.sup.2 denotes an ester-forming group of the carboxyl group, and the 4-methylthiazolyl group and the cephem moiety are cis to each other relative to the carbon-carbon double bond of the substituted vinyl group in the side chain at the 3-position of the cephem nucleus. The cephem compounds exhibit strong antibacterial activities not only against resistant strains of bacteria and gram-negative bacteria but also against gram-positive bacteria and moreover have very low toxicity.
Inventor(s): Yamamoto; Yuichi (Yokohama, JP), Atsumi; Kunio (Kawasaki, JP), Sakagami; Kenji (Kawasaki, JP), Yoshida; Takashi (Tokyo, JP), Nishihata; Ken (Yokohama, JP), Kondo; Sinichi (Yokohama, JP)
Assignee: Meiji Seika Kaisha, Ltd. (Tokyo, JP)
Application Number:07/019,172
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 4,918,068

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,918,068

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan61-44203Mar 03, 1986

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Dow
Fuji
Boehringer Ingelheim
Johnson and Johnson
US Army
Accenture
Teva
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.